FDA Adverse Event Injury Summary report: N

APTIMA COMBO 2 ASSAY

MDR report key: 25128789 · Received May 8, 2026

Report

Report Number
2024800-2026-00021
Event Type
Injury
Date Received
May 8, 2026
Date of Event
April 29, 2026
Report Date
May 8, 2026
Manufacturer
HOLOGIC, INC.
Product Code
LSL
UDI-DI
15420045505711
PMA / PMN Number
K111409
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

HOLOGIC REVIEWED THE PANTHER LOG FILES AND WORKLISTS AND NOTED THERE WERE NO INDICATIONS OF HARDWARE OR REAGENT PREPARATION ISSUES THAT AFFECTED RESULTS. THE DISCREPANT RESULT APPEARED TO BE SAMPLE RELATED, POSSIBLY DUE TO LOW TARGET CONCENTRATION OR SAMPLE MISHANDLING. HOLOGIC HAS NOT BEEN INFORMED OF ANY ADVERSE PATIENT OUTCOMES RELATED TO THIS ISSUE.

Description of Event or Problem · 0

ON APRIL 29, 2026, CUSTOMER REPORTED TO HOLOGIC RECEIVING DISCREPANT RESULTS WHILE PERFORMING A LOT-TO-LOT VERIFICATION FOR SAMPLE ID (SID): (B)(6) WHILE USING THE APTIMA COMBO 2 ASSAY ON THEIR PANTHER INSTRUMENT WITH SERIAL NUMBER (SN): (B)(6). ON (B)(6) 2026, SID: (B)(6) WAS INITIALLY TESTED ON WORKLIST (WL) (B)(4) (ML 924056) ON PANTHER INSTRUMENT (SN: (B)(6) AND RESULTED CT NEGATIVE/GC POSITIVE. ON (B)(6) 2026, CUSTOMER RETESTED SID: (B)(6) ON WORKLIST (B)(4) (ML 926168) ON PANTHER INSTRUMENT (SN: (B)(6) AND THE SAMPLE RESULTED CT POSITIVE/GC POSITIVE. ACCORDING TO THE CUSTOMER, THE FIRST VALID RESULT WAS REPORTED TO THE PATIENT. CUSTOMER DID NOT PROVIDE ANY INFORMATION ON THE PATIENT OR PATIENT TREATMENT. HOLOGIC HAS NOT BEEN INFORMED OF ANY ADVERSE PATIENT OUTCOMES RELATED TO THIS ISSUE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
22839 APTIMA COMBO 2 ASSAY DNA-REAGENTS, NEISSERIA LSL HOLOGIC, INC. 924056, 926168 15420045505711

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other